Previous close | 7.76 |
Open | 7.76 |
Bid | 7.86 x 100 |
Ask | 7.96 x 100 |
Day's range | 7.73 - 8.45 |
52-week range | 2.83 - 9.01 |
Volume | |
Avg. volume | 350,274 |
Market cap | 216.925M |
Beta (5Y monthly) | 1.48 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.53 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 21.00 |
CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On March 31, 2024, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to seven individuals hired by Abeona, which equity awards relate to, in the
We can readily understand why investors are attracted to unprofitable companies. By way of example, Abeona Therapeutics...
Completion of FDA Inspections Marks Progress Towards PDUFA Date